---All---
  • ---All---
  • Accession
  • Catalog #

ACTA1/?-actin Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP17487b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP17487b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ACTA1/?-actin Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP68133
Other AccessionP60010, P68136, P68135, P68137, P68134, P68139, P68138, P63269, P63268, P63267, P63270, Q5E9B5, A2BDB0, P63259, P63260, P63261, Q5ZMQ2, P63258, P04751, P68035, P68033, P68032, P68034, Q3ZC07, O93400, P60711, P29751, Q6QAQ1, P60710, Q4R561, P60709, P48975;
ReactivityHuman
PredictedBovine, Chicken, Drosophila, C.Elegans, Hamster, Mouse, Pig, Monkey, Rat, Rabbit, Xenopus, Yeast, Zebrafish
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW42051 Da

ACTA1/?-actin Antibody (C-term) - Additional info

Gene ID 58
Other Names
ACTA1; ACTA; Actin, alpha skeletal muscle; Alpha-actin-1
Target/Specificity
This ACTA1/?-actin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 188-217 amino acids from the C-terminal region of human ACTA1/?-actin.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
ACTA1/?-actin Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

ACTA1/?-actin Antibody (C-term) - Protein Information

Name ACTA1
Synonyms ACTA
Function
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells
Cellular Location
Cytoplasm, cytoskeleton.

ACTA1/?-actin Antibody (C-term) - Related products

AM1965a: ACTA1 Antibody (Ascites)

AM1965b: ACTA1 Antibody

AP14779b: ACTA1/?-actin Antibody (C-term)

AP17487b: ACTA1/?-actin Antibody (C-term)

DC03457: Human ACTA1 cDNA Clone

LY12247a: ACTA1 Over-expression Lysate

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause nemaline myopathy type 3, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects.

REFERENCES

Kim, E.Y., et al. Am. J. Physiol. Renal Physiol. 299 (3), F594-F604 (2010) : Haigh, S.E., et al. Neuromuscul. Disord. 20(6):363-374(2010) Yu, G., et al. J Clin Neurosci 17(6):766-769(2010) Yu, C.H., et al. PLoS ONE 5 (7), E11878 (2010) : Licastro, F., et al. Curr. Pharm. Des. 16(7):783-788(2010)